Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Consort Med Plc ADR (CSRMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 04/30

(Values in U.S. thousands)

	04-2018	04-2017	04-2016	04-2015
Cash Flows From Operating Activities
Net Income	29,179	28,330	N/A	N/A
Depreciation Amortization	34,266	32,987	N/A	N/A
Accounts receivable	-22,353	906	N/A	N/A
Accounts payable and accrued liabilities	-1,606	1,294	N/A	N/A
Other Working Capital	-20,747	-5,821	N/A	N/A
Other Operating Activity	24,629	-5,045	0	0
Operating Cash Flow	$43,367	$52,650	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-27,975	-23,285	N/A	N/A
Purchase Of Investment	0	-4,010	N/A	N/A
Purchase Sale Intangibles	-1,740	-129	N/A	N/A
Other Investing Activity	-1,472	0	0	0
Investing Cash Flow	$-29,447	$-27,295	$N/A	$N/A

Cash Flows From Financing Activities
Debt Issued	20,881	15,911	N/A	N/A
Debt Repayment	-16,999	-21,215	N/A	N/A
Common Stock Issued	669	776	N/A	N/A
Common Stock Repurchased	-2,945	-3,881	N/A	N/A
Dividend Paid	-13,519	-12,419	N/A	N/A
Financing Cash Flow	$-11,913	$-20,827	$N/A	$N/A

Exchange Rate Effect	669	-388	N/A	N/A
Beginning Cash Position	25,967	20,956	N/A	N/A
End Cash Position	28,644	25,096	N/A	N/A
Net Cash Flow	$2,677	$4,140	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	43,367	52,650	N/A	N/A
Capital Expenditure	-27,975	-23,285	N/A	N/A
Free Cash Flow	15,393	29,365	0	0